PainReform Ltd. Announces Receipt Of Extension To August 7, 2023 Meet The Nasdaq’s Minimum Bid Price Requirement
PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, announced